Unveiling Compugen's Potential and Key Strengths
In the dynamic realm of biotechnology, companies are often propelled into the spotlight when groundbreaking partnerships and promising drug candidates come to light. Compugen Ltd (NASDAQ: NASDAQ:CGEN ) is one such company that has recently made headlines with its collaboration with Gilead Sciences